Table 2.
ADNI | Cohort B | Cohort C | ||||
---|---|---|---|---|---|---|
NC (n = 85) | MCI (n = 129) | AD (n = 68) | NC, MCI, AD (n = 68) | NC (n = 47) | ||
PC1 | t-Taua | 0.724 | 0.871 | 0.831 | 0.577 | 0.734 |
p-Tau181a | 0.805 | 0.866 | 0.826 | 0.474 | 0.727 | |
Aβ42a | −0.752 | −0.745 | −0.612 | −0.781 | −0.595 | |
t-Tau/Aβ42a | 0.710 | 0.675 | 0.774 | 0.923 | 0.925 | |
PC2 | sTNFR1a | 0.869 | 0.903 | 0.884 | 0.895 | 0.851 |
sTNRF2a | 0.784 | 0.883 | 0.881 | 0.859 | 0.850 | |
sVCAM1a | 0.833 | 0.869 | 0.813 | 0.833 | 0.825 | |
TGFβ1a | 0.533 | 0.469 | 0.561 | N.D. | N.D. | |
sICAM1a | 0.502 | 0.467 | 0.661 | |||
IP-10 | 0.484 | 0.602 | N.D. | |||
PC3 | MSD-sTREM2a | 0.876 | 0.883 | 0.876 | 0.639b | 0.787b |
WU-sTREM2a | 0.830 | 0.882 | 0.819 | |||
Progranulin | 0.519 | 0.640 | N.D. | N.D. | ||
PC4 | IL-6a | 0.811 | 0.799 | 0.828 | N.D. | N.D. |
IL-10a | 0.691 | 0.662 | 0.713 | 0.922 | 0.812 | |
PC5 | TGFβ2a | 0.885 | 0.820 | 0.754 | N.D. | N.D. |
TGFβ1a | 0.598 | 0.716 | 0.752 | N.D. | N.D. | |
TGFβ3 | 0.538 | 0.705 | N.D. | N.D. | ||
PC6 | IL-7a | 0.866 | 0.810 | 0.797 | 0.912 | 0.942 |
TNF-αa | 0.753 | 0.429 | 0.707 | 0.757 | ||
IL-9 | 0.601 | 0.647 | ||||
PC7 | IP-10 | 0.722 | 0.705 | N.D. | ||
IL12-p40 | 0.686 | 0.772 | N.D. | N.D. | ||
IL-9 | 0.571 | 0.865 | ||||
PC8 | IL-21 | 0.458 | 0.904 | N.D. | N.D. | |
sICAM1 | −0.624 | 0.934 |
aProteins found in the same PC across ADNI diagnostic groups. Levels of IL-6, IL-12p40, IL-21, progranulin, and TGFβ1/2/3 were not measured in either replication cohort, and IP-10 was not measured in Cohort C.
bDifferent sTREM2 assays used between ADNI and the replication cohorts.